Eye Care - Switzerland

  • Switzerland
  • In Switzerland, the revenue generated in the Eye Care market market is estimated to be US$41.81m in 2024.
  • It is projected to experience an annual growth rate of 2.44% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, reaching US$1,256.00m in 2024.
  • Considering the total population, per person revenues amount to US$4.72 in 2024.
  • Switzerland's Eye Care market is witnessing a growing demand for innovative and premium products due to its affluent population and high healthcare standards.

Key regions: Australia, Japan, Brazil, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in Switzerland is experiencing steady growth and development due to various factors.

Customer preferences:
Swiss customers have a high level of awareness and concern for their eye health, which has led to an increased demand for eye care products and services. They value quality and reliability when it comes to their eye care needs, and are willing to invest in premium products that offer superior performance and comfort. Additionally, Swiss customers are becoming more conscious about the environmental impact of their purchases, leading to a growing interest in sustainable and eco-friendly eye care options.

Trends in the market:
One notable trend in the Swiss Eye Care market is the rising popularity of contact lenses. Contact lenses offer convenience and freedom from wearing glasses, which appeals to customers with active lifestyles. The demand for contact lenses has also been driven by technological advancements, such as the development of silicone hydrogel lenses that provide better oxygen permeability and comfort. Another trend is the increasing adoption of digital eye care solutions. With the rise in digital devices usage, Swiss customers are experiencing more eye strain and are seeking products and services that can alleviate digital eye fatigue. This has led to the emergence of blue light filter glasses and eye drops that help protect and soothe the eyes from the harmful effects of prolonged screen time.

Local special circumstances:
Switzerland has a high standard of living and a well-developed healthcare system, which has contributed to the growth of the Eye Care market. The country has a strong tradition of precision engineering and innovation, which has resulted in the production of high-quality eye care products. Swiss customers have access to a wide range of eye care providers, including opticians, ophthalmologists, and online retailers, allowing them to choose the most convenient and suitable option for their needs. Additionally, Switzerland has a large aging population, which has increased the demand for vision correction solutions such as prescription glasses and cataract surgeries.

Underlying macroeconomic factors:
The Swiss economy is stable and prosperous, with a high level of disposable income among its population. This has enabled Swiss customers to afford premium eye care products and services. Furthermore, the country has a strong culture of preventive healthcare, with regular eye examinations being a common practice. This emphasis on preventive care has contributed to the growth of the Eye Care market, as customers are more likely to seek professional advice and invest in products that can help maintain their eye health. The Swiss government also provides comprehensive health insurance coverage, which includes vision care, further encouraging customers to prioritize their eye health.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)